Myokines and adipokines: Involvement in the crosstalk between skeletal muscle and adipose tissue

Cytokine and Growth Factor Reviews

Volumn 33, Issue , 2017, Pages 73-82

  Li, Fengna ^a,b   Li, Yinghui ^a,c   Duan, Yehui ^a,c   Hu, Chien An A ^d   Tang, Yulong ^a   Yin, Yulong ^a,e  

^a INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^b Hunan Co Innovation Center of Animal Production Safety (CICAPS)   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^d UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^e HUNAN NORMAL UNIVERSITY   (China)

Author keywords

Adipo myokines; Adipokines; Myokines; Secretomics

Indexed keywords

ADIPONECTIN; CHEMERIN; CYTOKINE; FIBROBLAST GROWTH FACTOR 21; INTERLEUKIN 15; INTERLEUKIN 6; INTERLEUKIN 8; IRISIN; LEPTIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; MYONECTIN; MYOSTATIN; NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; RESISTIN; SIRTUIN 1; SIRTUIN 4; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2; ADIPOCYTOKINE; MUSCLE PROTEIN; PROTEOME;

ADIPOSE TISSUE; BIOMICS; CELL PROLIFERATION; CYTOKINE PRODUCTION; CYTOKINE RELEASE; ENERGY METABOLISM; ENZYME INHIBITION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPID HOMEOSTASIS; NONHUMAN; OBESITY; PROTEIN BINDING; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEOMICS; REVIEW; SECRETOMICS; SKELETAL MUSCLE; ADIPOCYTE; ANIMAL; CELL COMMUNICATION; METABOLISM; MOUSE; MUSCLE CELL; SIGNAL TRANSDUCTION;

ADIPOCYTES; ADIPOKINES; ADIPOSE TISSUE; ANIMALS; CELL COMMUNICATION; HUMANS; INTERLEUKIN-15; INTERLEUKIN-6; INTERLEUKIN-8; MICE; MUSCLE CELLS; MUSCLE PROTEINS; MUSCLE, SKELETAL; OBESITY; PROTEOME; SIGNAL TRANSDUCTION;

EID: 85005896421     PISSN: 13596101     EISSN: 18790305     Source Type: Journal    
DOI: 10.1016/j.cytogfr.2016.10.003     Document Type: Review

References (116)

1. [1] World Health Organization. Media centre: Obesity and overweight (2015).
2. [2] Kershaw, E.E., Flier, J.S., Adipose tissue as an endocrine organ. J. Clin. Endocrinol. Metab. 89:6 (2004), 2548–2556.
3. [3] Yang, H.S., Li, F.N., Kong, X.F., Yuan, X.X., Wang, W.C., Huang, R.L., Li, T.J., Geng, M.M., Wu, G.Y., Yin, Y.L., Chemerin regulates proliferation and differentiation of myoblast cells via ERK1/2 and mTOR signaling pathways. Cytokine 60:3 (2012), 646–652.
4. [4] Li, Y.H., Li, F.N., Lin, B.B., Kong, X.F., Tang, Y.L., Yin, Y.L., Myokine IL-15 regulates the crosstalk of co-cultured porcine skeletal muscle satellite cells and preadipocytes. Mol. Biol. Rep. 41 (2014), 7543–7553.
5. [5] Ojimaa, K., Oea, M., Nakajimaa, I., Shibatab, M., Chikunia, K., Muroyaa, S., Nishimurac, T., Proteomic analysis of secreted proteins from skeletal muscle cells during differentiation. Eu Pa Open Proteomics 5 (2014), 1–9.
6. [6] Lee, H.J., Lee, J.O., Kim, N., Kim, J.K., Kim, H.I., Lee, Y.W., Kim, S.J., Choi, J.I., Oh, Y., Kim, J.H., Suyeon-Hwang Park, S.H., Kim, H.S., Irisin: a novel myokine, regulates glucose uptake in skeletal muscle cells via AMPK. Mol. Endocrinol. 29:6 (2015), 873–881.
7. [7] Krzysik-Walker, S.M., Ocón-Grove, O.M., Maddineni, S.R., Hendricks, G.L., Ramachandran, R., Is visfatin an adipokine or myokine? Evidence for greater visfatin expression in skeletal muscle than visceral fat in chickens. Endocrinology 149:4 (2008), 1543–1550.
8. [8] Boström, P., Wu, J., Jedrychowski, M.P., Korde, A., Ye, L., Lo, J.C., Rasbach, K.A., Boström, E.A., Choi, J.H., Long, J.Z., Kajimura, S., Zingaretti, M.C., Vind, B.F., Tu, H., Cinti, S., Højlund, K., Gygi, S.P., Spiegelman, B.M., A PGC1- alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481 (2012), 463–468.
9. [9] DeFronzo, R.A., Jacot, E., Jequier, E., Maeder, E., Wahren, J., Felber, J.P., The effect of insulin on the disposal of intravenous glucose: results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30 (1981), 1000–1007.
10. [10] Peppa, M., Koliaki, C., Nikolopoulos, P., Raptis, S.A., Skeletal muscle insulin resistance in endocrine disease. J. Biomed. Biotechnol., 2010, 2010, 527850.
11. [11] Steensberg, A., van, H.G., Osada, T., Sacchetti, M., Saltin, B., Klarlund, P.B., Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J. Physiol. 529Pt 1 (2000), 237–242.
12. [12] Pedersen, B.K., Febbraio, M.A., Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol. Rev. 88 (2008), 1379–1406.
13. [13] Wang, G.X., Zhao, X.Y., Lin, J.D., The brown fat secretome: metabolic functions beyond thermogenesis. Trends Endocrinol. Metab. 26:5 (2015), 231–237.
14. [14] Caesar, R., Manieri, M., Kelder, T., Boekschoten, M., Evelo, C., Muller, M., Kooistra, T., Cinti, S., Kleemann, R., Drevon, C.A., A combined transcriptomics and lipidomics analysis of subcutaneous, epididymal and mesenteric adipose tissue reveals marked functional differences. PLoS One, 5, 2010, e11525.
15. [15] Galpin, A.J., Raue, U., Jemiolo, B., Trappe, T.A., Harber, M.P., Minchev, K., Trappe, S., Human skeletal muscle fiber type specific protein content. Anal. Biochem. 425:2 (2012), 175–182.
16. [16] Boone, C., Mourot, J., Gregiore, F., Remacle, C., The adipose conversion process: regulation by extracellular and intracellular factors. Reprod. Nutr. Dev. 40 (2000), 325–358.
17. [17] Fruhbeck, G., Gomez-Ambrosi, J., Muruzabal, F.J., Burrell, M.A., The adipocyte: a model for integration of endocrine and metabolic signaling in energy metabolism regulation. Am. J. Physiol. 280 (2001), E827–E847.
18. [18] Diamond, F., The endocrine function of adipose tissue. Growth Genet. Hormones 18 (2002), 17–23.
19. [19] Dietze, D., Koenen, M., Röhrig, K., Horikoshi, H., Hauner, H., Eckel, J., Impairment of insulin signaling in human skeletal muscle cells by co-culture with human adipocytes. Diabetes 51 (2002), 2369–2376.
20. [20] Pedersen, B.K., Edward, F., Adolph distinguished lecture: muscle as an endocrine organ: IL-6 and other myokines. J. Appl. Physiol. 107 (2009), 1006–1014.
21. [21] Joulia, D., Bernardi, H., Garandel, V., Rabenoelina, F., Vernus, B., Cabello, G., Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin. Exp. Cell. Res. 286:2 (2003), 263–275.
22. [22] Wang, M., Yu, H., Kim, Y.S., Bidwell, C.A., Kuang, S., Myostatin facilitates slow and inhibits fast myosin heavy chain expression during myogenic differentiation. Biochem. Biophys. Res. Commun. 426:1 (2012), 83–88.
23. [23] Cleasby, M.E., Jarmin, S., Eilers, W., Elashry, M., Andersen, D.K., Dickson, G., Foster, K., Local overexpression of the myostatin propeptide increases glucose transporter expression and enhances skeletal muscle glucose disposal. Am. J. Physiol. Endocrinol. Metab. 306:7 (2014), E814–23.
24. [24] Allen, D.L., Cleary, A.S., Speaker, K.J., Lindsay, S.F., Uyenishi, J., Reed, J.M., Madden, M.C., Mehan, R.S., Myostatin: activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice. Am. J. Physiol. Endocrinol. Metab. 294:5 (2008), E918–27.
25. [25] Wilkes, J.J., Lloyd, D.J., Gekakis, N., Loss-of-function mutation in myostatin reduces tumor necrosis factor alpha production and protects liver against obesity-induced insulin resistance. Diabetes 58 (2009), 1133–1143.
26. [26] McPherron, A.C., Lawler, A.M., Lee, S.J., Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 387:6628 (1997), 83–90.
27. [27] Schuelke, M., Wagner, K.R., Stolz, L.E., Hübner, C., Riebel, T., Kömen, W., Braun, T., Tobin, J.F., Lee, S.J., Myostatin mutation associated with gross muscle hypertrophy in a child. N. Engl. J. Med. 350 (2004), 2682–2688.
28. [28] Shan, T., Liang, X., Bi, P., Kuang, S., Myostatin knockout drives browning of white adipose tissue through activating the AMPK-PGC1α-Fndc5 pathway in muscle. FASEB J. 27:5 (2013), 1981–1989.
29. [29] Guo, T., Jou, W., Chanturiya, T., Portas, J., Gavrilova, O., McPherron, A.C., Myostatin inhibition in muscle, but not adipose tissue, decreases fat mass and improves insulin sensitivity. PLoS One, 4(3), 2009, e4937.
30. [30] Lee, J.Y., Hopkinson, N.S., Kemp, P.R., Myostatin induces autophagy in skeletal muscle in vitro. Biochem. Biophys. Res. Commun. 415:4 (2011), 632–636.
31. [31] Elliott, B., Renshaw, D., Getting, S., Mackenzie, R., The central role of myostatin in skeletal muscle and whole body homeostasis. Acta Physiol (Oxf.) 205:3 (2012), 324–340.
32. [32] Szalay, K., Razga, Z., Duda, E., TNF inhibits myogenesis and downregulates the expression of myogenic regulatory factors myoD and myogenin. Eur. J. Cell. Biol. 74 (1997), 391–398.
33. [33] Amir Levy, Y., Ciaraldi, T.P., Mudaliar, S.R., Phillips, S.A., Henry, R.R., Excessive secretion of IL-8 by skeletal muscle in type 2 diabetes impairs tube growth: potential role of PI3K and the Tie2 receptor. Am. J. Physiol. Endocrinol. Metab. 309:1 (2015), E22–34.
34. [34] Bruun, J.M., Lihn, A.S., Madan, A.K., Pedersen, S.B., Schiøtt, K.M., Fain, J.N., Richelsen, B., Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue. Am. J. Physiol. Endocrinol. Metab. 286:1 (2004), E8–13.
35. [35] Lihn, A.S., Pedersen, S.B., Lund, S., Richelsen, B., The anti-diabetic AMPK activator AICAR reduces IL-6 and IL-8 in human adipose tissue and skeletal muscle cells. Mol. Cell. Endocrinol. 292:1–2 (2008), 36–41.
36. [36] Pedersen, B.K., Akerstrom, T.C., Nielsen, A.R., Fische, C.P., Role of myokines in exercise and metabolism. J. Appl. Physiol. 103:3 (2007), 1090–1093.
37. [37] CarbóN. López-Soriano, J., Costelli, P., Alvarez, B., Busquets, S., Baccino, F.M., Quinn, L.S., López-Soriano, F.J., Argilés, J.M., Interleukin-15 mediates reciprocal regulation of adipose and muscle mass: a potential role in body weight control. Biochim. Biophys. Acta 1526:1 (2001), 17–24.
38. [38] Nielsen, A.R., Hojman, P., Erikstrup, C., Fischer, C.P., Plomgaard, P., Mounier, R., Mortensen, O.H., Broholm, C., Taudorf, S., Krogh-Madsen, R., Lindegaard, B., Petersen, A.M., Gehl, J., Pedersen, B.K., Association between interleukin-15 and obesity: interelukin-15 as a potential regulator of fat mass. J. Clin. Endocrinol. Metab. 93:11 (2008), 4486–4493.
39. [39] Quinn, L.S., Anderson, B.G., Strait-Bodey, L., Stroud, A.M., Argilés, J.M., Oversecretion of interleukin-15 from skeletal muscle reduces adiposity. Am. J. Physiol. 296:1 (2009), E191–202.
40. [40] Barra, N.G., Reid, S., MacKenzie, R., Werstuck, G., Trigatti, B.L., Richards, C., Holloway, A.C., Ashkar, A.A., Interleukin-15 contributes to the regulation of murine adipose tissue and human adipocytes. Obesity 18:8 (2010), 1601–1607.
41. [41] Quinn, L.S., Anderson, B.G., Conner, J.D., Pistilli, E.E., Wolden-Hanson, T., Overexpression of interleukin-15 in mice promotes resistance to diet-induced obesity, increased insulin sensitivity, and markers of oxidative skeletal muscle metabolism. Int. J. Interferon. Cytokine Mediator Res. 3 (2011), 29–42.
42. [42] Barra, N.G., Palanivel, R., Denou, E., Chew, M.V., Gillgrass, A., Walker, T.D., Kong, J., Richards, C.D., Jordana, M., Collins, S.M., Trigatti, B.L., Holloway, A.C., Raha, S., Steinberg, G.R., Ashkar, A.A., Interleukin-15 modulates adipose tissue by altering mitochondrial mass and activity. PLoS One, 9(12), 2014, e114799.
43. [43] Mashili, F.L., Austin, R.L., Deshmukh, A.S., Fritz, T., Caidahl, K., Bergdahl, K., Zierath, J.R., Chibalin, A.V., Moller, D.E., Kharitonenkov, A., Krook, A., Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity. Diabetes Metab. Res. Rev. 27:3 (2011), 286–297.
44. [44] Ji, K., Zheng, J., Lv, J., Xu, J., Ji, X., Luo, Y.B., Li, W., Zhao, Y., Yan, C., Skeletal muscle increases FGF21 expression in mitochondrial disorders to compensate for energy metabolic insufficiency by activating the mTOR-YY1-PGC1α pathway. Free Radic. Biol. Med. 84 (2015), 161–170.
45. [45] Potthoff, M.J., Inagaki, T., Satapati, S., Ding, X., He, T., Goetz, R., Mohammadi, M., Finck, B.N., Mangelsdorf, D.J., Kliewer, S.A., Burgess, S.C., FGF21 induces PGC-1alpha and regulates carbohydrate and fatty acid metabolism during the adaptive starvation response. Proc. Natl. Acad. Sci. U. S. A. 106:26 (2009), 10853–10858.
46. [46] Lin, Z., Tian, H., Lam, K.S., Lin, S., Hoo, R.C., Konishi, M., Itoh, N., Wang, Y., Bornstein, S.R., Xu, A., Li, X., Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice. Cell. Metab. 17 (2013), 779–789.
47. [47] Holland, W.L., Adams, A.C., Brozinick, J.T., Bui, H.H., Miyauchi, Y., Kusminski, C.M., Bauer, S.M., Wade, M., Singhal, E., Cheng, C.C., Volk, K., Kuo, M.S., Gordillo, R., Kharitonenkov, A., Scherer, P.E., An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell. Metab. 17 (2013), 790–797.
48. [48] Hotta, Y., Nakamura, H., Konishi, M., Murata, Y., Takagi, H., Matsumura, S., Inoue, K., Fushiki, T., Itoh, N., Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver. Endocrinology 150:10 (2009), 4625–4633.
49. [49] Fisher, F.M., Kleiner, S., Douris, N., Fox, E.C., Mepani, R.J., Verdeguer, F., Wu, J., Kharitonenkov, A., Flier, J.S., Maratos-Flier, E., Spiegelman, B.M., FGF21 regulates PGC-1alpha and browning of white adipose tissues in adaptive thermogenesis. Genes Dev. 26 (2012), 271–281.
50. [50] Lee, P., Linderman, J.D., Smith, S., Brychta, R.J., Wang, J., Idelson, C., Perron, R.M., Werner, C.D., Phan, G.Q., Kammula, U.S., Kebebew, E., Pacak, K., Chen, K.Y., Celi, F.S., Irisin and FGF21 are cold-induced endocrine activators of brown fat function in humans. Cell. Metab. 19 (2014), 302–309.
51. [51] Keipert, S., Ost, M., Johann, K., Imber, F., Jastroch, M., van Schothorst, E.M., Keijer, J., Klaus, S., Skeletal muscle mitochondrial uncoupling drives endocrine cross-talk through the induction of FGF21 as a myokine. Am. J. Physiol. Endocrinol. Metab. 306:5 (2014), E469–82.
52. [52] Moyers, J.S., Shiyanova, T.L., Mehrbod, F., Dunbar, J.D., Noblitt, T.W., Otto, K.A., Reifel-Miller, A., Kharitonenkov, A., Molecular determinants of FGF21 activity-synergy and cross-talk with PPAR gamma signaling. J. Cell. Physiol. 210 (2007), 1–6.
53. [53] Vaughan, R.A., Gannon, N.P., Barberena, M.A., Garcia-Smith, R., Bisoffi, M., Mermier, C.M., Conn, C.A., Trujillo, K.A., Characterization of the metabolic effects of irisin on skeletal muscle in vitro. Diabetes Obes. Metab. 16:8 (2014), 711–718.
54. [54] Moreno-Navarrete, J.M., Ortega, F., Serrano, M., Guerra, E., Pardo, G., Tinahones, F., Ricart, W., Fernández-Real, J.M., Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J. Clin. Endocrinol. Metab. 98 (2013), E769–78.
55. [55] Huh, J.Y., Dincer, F., Mesfum, E., Mantzoros, C.S., Irisin stimulates muscle growth-related genes and regulates adipocyte differentiation and metabolism in humans. Int. J. Obes. (Lond.) 38:12 (2014), 1538–1544.
56. [56] Zhang, Y., Li, R., Meng, Y., Li, S., Donelan, W., Zhao, Y., Qi, L., Zhang, M., Wang, X., Cui, T., Yang, L.J., Tang, D., Irisin stimulates browning of white adipocytes through mitogen-activated protein kinase p38 MAP kinase and ERK MAP kinase signaling. Diabetes 63:2 (2014), 514–525.
57. [57] Seldin, M.M., Peterson, J.M., Byerly, M.S., Wei, Z., Wong, G.W., Myonectin (CTRP15): a novel myokine that links skeletal muscle to systemic lipid homeostasis. J. Biol. Chem. 287:15 (2012), 11968–11980.
58. [58] Seldin, M.M., Wong, G.W., Regulation of tissue crosstalk by skeletal muscle-derived myonectin and other myokines. Adipocyte 1:4 (2012), 200–202.
59. [59] Zhang, Y., Proenca, R., Maffei, M., Barone, M., Leopold, L., Friedman, J.M., Positional cloning of the mouse obese gene and its human homologue. Nature 372 (1994), 425–432.
60. [60] Cancello, R., Zingaretti, M.C., Sarzani, R., Ricquier, D., Cinti, S., leptin and UCP1 genes are reciprocally regulated in brown adipose tissue. Endocrinology 11 (1998), 4747–4750.
61. [61] Zhang, Y., Guo, K.Y., Diaz, P.A., Heo, M., Leibel, R.L., Determinants of leptin gene expression in fat depots of lean mice. Am. J. Physiol. 282 (2001), R216–34.
62. [62] Wang, J., Liu, R., Hawkins, M., Barzilai, N., Rossetti, L., A nutrient-sensing pathway regulates leptin gene expression in muscle and fat. Nature 393 (1998), 684–688.
63. [63] Wolsk, E., Mygind, H., Grøndahl, T.S., Pedersen, B.K., van Hall, G., Human skeletal muscle releases leptin in vivo. Cytokine 60:3 (2012), 667–673.
64. [64] Sendlhofer, G., Brunner, G., Schaupp, L., Wutte, A., Ellmerer, M., Pieber, T.R., Estimation of human leptin concentration in the subcutaneous adipose and skeletal muscle tissues. Eur. J. Clin. Invest. 45:5 (2015), 445–451.
65. [65] Mao, X., Zeng, X., Huang, Z., Wang, J., Qiao, S., Leptin and leucine synergistically regulate protein metabolism in C2C12 myotubes and mouse skeletal muscles. Br. J. Nutr. 110:2 (2013), 256–264.
66. [66] Toda, C., Shiuchi, T., Kageyama, H., Okamoto, S., Coutinho, E.A., Sato, T., Okamatsu-Ogura, Y., Yokota, S., Takagi, K., Tang, L., Saito, K., Shioda, S., Minokoshi, Y., Extracellular signal-regulated kinase in the ventromedial hypothalamus mediates leptin-induced glucose uptake in red-type skeletal muscle. Diabetes 62:7 (2013), 2295–2307.
67. [67] Zhang, Y., Matheny, M., Zolotukhin, S., Tumer, N., Scarpace, P.J., Regulation of adiponectin and leptin gene expression in white and brown adipose tissues: influence of beta3- adrenergic agonists, retinoic acid, leptin and fasting. Biochim. Biophys. Acta 1584 (2002), 115–122.
68. [68] Turer, A.T., Scherer, P.E., Adiponectin: mechanistic insights and clinical implications. Diabetologia 55 (2012), 2319–2326.
69. [69] Yamauchi, T., Kadowaki, T., Adiponectin receptor as a key player in healthy longevity and obesity-related diseases. Cell. Metab. 17 (2013), 185–196.
70. [70] Turer, A.T., Khera, A., Ayers, C.R., Turer, C.B., Grundy, S.M., Vega, G.L., Scherer, P.E., Adipose tissue mass and location affect circulating adiponectin levels. Diabetologia 54:10 (2011), 2515–2524.
71. [71] Combs, T.P., Pajvani, U.B., Berg, A.H., Lin, Y., Jelicks, L.A., Laplante, M., Nawrocki, A.R., Rajala, M.W., Parlow, A.F., Cheeseboro, L., Ding, Y.Y., Russell, R.G., Lindemann, D., Hartley, A., Baker, G.R., Obici, S., Deshaies, Y., Ludgate, M., Rossetti, L., Scherer, P.E., A transgenic mouse with a deletion in the collagenous domain of adiponectin displays elevated circulating adiponectin and improved insulin sensitivity. Endocrinology 145:1 (2004), 367–383.
72. [72] Tomas, E., Tsao, T.S., Saha, A.K., Murrey, H.E., Zhang, C.C., Itani, S.I., Lodish, H.F., Ruderman, N.B., Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation. Proc. Natl. Acad. Sci. U. S. A. 99:25 (2002), 16309–16313.
73. [73] Yoon, M.J., Lee, G.Y., Chung, J.J., Ahn, Y.H., Hong, S.H., Kim, J.B., Adiponectin increases fatty acid oxidation in skeletal muscle cells by sequential activation of AMP-activated protein kinase: p38 mitogen-activated protein kinase, and peroxisome proliferator-activated receptor alpha. Diabetes 55:9 (2006), 2562–2570.
74. (2+) and AMPK/SIRT1. Nature 464:7293 (2010), 1313–1319.
75. [75] Xin, X., Zhou, L., Reyes, C.M., Liu, F., Dong, L.Q., APPL1 mediates adiponectin-stimulated p38 MAPK activation by scaffolding the TAK1-MKK3-p38 MAPK pathway. Am. J. Physiol. Endocrinol. Metab. 300:1 (2011), E103–10.
76. [76] Qiao, L., Kinney, B., Yoo, H.S., Lee, B., Schaack, J., Shao, J., Adiponectin increases skeletal muscle mitochondrial biogenesis by suppressing mitogen-activated protein kinase phosphatase-1. Diabetes 61:6 (2012), 1463–1470.
77. [77] Liu, Y., Palanivel, R., Rai, E., Park, M., Gabor, T.V., Scheid, M.P., Xu, A., Sweeney, G., Adiponectin stimulates autophagy and reduces oxidative stress to enhance insulin sensitivity during high-fat diet feeding in mice. Diabetes 64:1 (2015), 36–48.
78. [78] Palanivel, R., Sweeney, G., Regulation of fatty acid uptake and metabolism in L6 skeletal muscle cells by resistin. FEBS Lett. 579:22 (2005), 5049–5054.
79. [79] Palanivel, R., Maida, A., Liu, Y., Sweeney, G., Regulation of insulin signalling, glucose uptake and metabolism in rat skeletal muscle cells upon prolonged exposure to resistin. Diabetologia 49:1 (2006), 183–190.
80. [80] Jørgensen, S.B., Honeyman, J., Oakhill, J.S., Fazakerley, D., Stöckli, J., Kemp, B.E., Steinberg, G.R., Oligomeric resistin impairs insulin and AICAR-stimulated glucose uptake in mouse skeletal muscle by inhibiting GLUT4 translocation. Am. J. Physiol. Endocrinol. Metab. 297:1 (2009), E57–66.
81. [81] Chen, N., Zhou, L., Zhang, Z., Xu, J., Wan, Z., Qin, L., Resistin induces lipolysis and suppresses adiponectin secretion in cultured human visceral adipose tissue. Regul. Pept. 194–195 (2014), 49–54.
82. [82] Popovic, D.S., Tomic-Naglic, D., Stokic, E., Relation of resistin, leptin and adiponectin-trinity of adipose tissue dysfunction assessment. Eur. J. Intern. Med. 25:6 (2014), e80–e81.
83. [83] Goralski, K.B., McCarthy, T.C., Hanniman, E.A., Zabel, B.A., Butcher, E.C., Parlee, S.D., Muruganandan, S., Sinal, C.J., Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J. Biol. Chem. 282 (2007), 28175–28188.
84. [84] Shin, H.Y., Lee, D.C., Chu, S.H., Jeon, J.Y., Lee, M.K., Im, J.A., Lee, J.W., Chemerin levels are positively correlated with abdominal visceral fat accumulation. Clin. Endocrinol. (Oxf.) 77:1 (2012), 47–50.
85. [85] Ernst, M.C., Issa, M., Goralski, K.B., Sinal, C.J., Chemerin exacerbates glucose intolerance in mouse models of obesity and diabetes. Endocrinology 151:5 (2010), 1998–2007.
86. [86] Tan, B.K., Chen, J., Brown, J., Adya, R., Ramanjaneya, M., Menon, V., Bailey, C.J., Lehnert, H., Randeva, H.S., In vivo and ex vivo regulation of visfatin production by leptin in human and murine adipose tissue: role of mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Endocrinology 150:8 (2009), 3530–3539.
87. [87] Rollins, B.J., Chemokines. Blood 90 (1997), 909–928.
88. [88] Gerhardt, C.C., Romero, I.A., Cancello, R., Camoin, L., Strosberg, A.D., Chemokines control fat accumulation and leptin secretion by cultured human adipocytes. Mol. Cell. Endocrinol. 175 (2001), 81–92.
89. [89] Zhou, H.R., Kim, E.K., Kim, H., Claycombe, K.J., Obesity-associated mouse adipose stem cell secretion of monocyte chemotactic protein-1. Am. J. Physiol. Endocrinol. Metab. 293:5 (2007), E1153–8.
90. [90] Sartipy, P., Loskutoff, D.J., Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 7265–7270.
91. [91] Sell, H., Dietze-Schroeder, D., Kaiser, U., Eckel, J., Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle. Endocrinology 147:5 (2006), 2458–2467.
92. [92] Sell, H., Eckardt, K., Taube, A., Tews, D., Gurgui, M., Van Echten-Deckert, G., Eckel, J., Skeletal muscle insulin resistance induced by adipocyte-conditioned medium: underlying mechanisms and reversibility. Am. J. Physiol. Endocrinol. Metab. 294:6 (2008), E1070–7.
93. [93] Raschke, S., Eckardt, K., Bjørklund Holven, K., Jensen, J., Eckel, J., Identification and validation of novel contraction-regulated myokines released from primary human skeletal muscle cells. PLoS One, 8(4), 2013, e62008.
94. [94] Ernst, M., Jenkins, B., Acquiring signalling specificity from the cytokine receptor gp130. Trends Genet. 20 (2004), 23–32.
95. [95] Keller, C., Steensberg, A., Pilegaard, H., Osada, T., Saltin, B., Pedersen, B.K., Neufer, P.D., Transcriptional activation of the IL-6 gene in human contracting skeletal muscle: influence of muscle glycogen content. FASEB J. 15:14 (2001), 2748–2750.
96. [96] Plomgaard, P., Penkowa, M., Pedersen, B.K., Fiber type specific expression of TNF-alpha, IL-6 and IL-18 in human skeletal muscles. Exerc. Immunol. Rev. 11 (2005), 53–63.
97. [97] Chabowski, A., Zmijewska, M., Gorski, J., Bonen, A., Kaminski, K., Kozuch, M., Winnicka, M.M., IL-6 deficiency increases fatty amid transporters and intramuscular lipid content in red but not white skeletal muscle. J. Physiol. Pharmacol. 59 (2008), 105–117.
98. [98] van Hall, G., Steensberg, A., Sacchetti, M., Fischer, C., Keller, C., Schjerling, P., Hiscock, N., Moller, K., Saltin, B., Febbraio, M.A., Pedersen, B.K., Interleukin-6 stimulates lipolysis and fat oxidation in humans. J. Clin. Endocrinol. Metab. 88 (2003), 3005–3010.
99. [99] Trujillo, M.E., Sullivan, S., Harten, I., Schneider, S.H., Greenberg, A.S., Fried, S.K., Interleukin-6 regulates human adipose tissue lipid metabolism and leptin production in vitro. J. Clin. Endocrinol. Metab. 89:11 (2004), 5577–5582.
100. [100] Bastard, J.P., Maachi, M., Van Nhieu, J.T., Jardel, C., Bruckert, E., Grimaldi, A., Robert, J.J., Capeau, J., Hainque, B., Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro. J. Clin. Endocrinol. Metab. 87:5 (2002), 2084–2089.
101. [101] Knudsen, J.G., Bertholdt, L., Joensen, E., Lassen, S.B., Hidalgo, J., Pilegaard, H., Skeletal muscle interleukin-6 regulates metabolic factors in iWAT during HFD and exercise training. Obesity (Silver Spring) 23:8 (2015), 1616–1624.
102. [102] Hotamisligil, G.S., Arner, P., Caro, J.F., Atkinson, R.L., Spiegelman, B.M., Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. J. Clin. Invest. 95 (1995), 2409–2415.
103. [103] Zhao, Q., Yang, S.T., Wang, J.J., Zhou, J., Xing, S.S., Shen, C.C., Wang, X.X., Yue, Y.X., Song, J., Chen, M., Wei, Y.Y., Zhou, Q.P., Dai, T., Song, Y.H., TNF alpha inhibits myogenic differentiation of C2C12 cells through NF-κB activation and impairment of IGF-1 signaling pathway. Biochem. Biophys. Res. Commun. 458:4 (2015), 790–795.
104. [104] Steinberg, G.R., Michell, B.J., van Denderen, B.J., Watt, M.J., Carey, A.L., Fam, B.C., Andrikopoulos, S., Proietto, J., Görgün, C.Z., Carling, D., Hotamisligil, G.S., Febbraio, M.A., Kay, T.W., Kemp, B.E., Tumor necrosis factor alpha-induced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab. 4:6 (2006), 465–474.
105. [105] Duan, Y.H., Li, F.N., Li, L.L., Fan, J.X., Sun, X.M., Yin, Y.L., N-6: n-3 PUFA ratio is involved in regulating lipid metabolism and inflammation in pigs. Br. J. Nutr. 111 (2014), 445–451.
106. [106] Porter, M.H., Cutchins, A., Fine, J.B., Bai, Y., DiGirolamo, M., Effects of TNF-alpha on glucose metabolism and lipolysis in adipose tissue and isolated fat-cell preparations. J. Lab. Clin. Med. 139:3 (2002), 140–146.
107. [107] Rydén, M., Dicker, A., van Harmelen, V., Hauner, H., Brunnberg, M., Perbeck, L., Lonnqvist, F., Arner, P., Mapping of early signaling events in tumor necrosis factor-alpha -mediated lipolysis in human fat cells. J. Biol. Chem. 277:2 (2002), 1085–1091.
108. [108] Zubkova, E.S., Beloglazova, I.B., Makarevich, P.I., Boldyreva, M.A., Sukhareva, O.Y., Shestakova, M.V., Dergilev, K.V., Parfyonova, Y.V., Menshikov, M.Y., Regulation of adipose tissue stem cells angiogenic potential by tumor necrosis factor-alpha. J. Cell. Biochem. 117 (2016), 180–196.
109. [109] Rodríguez, A., Becerril, S., Méndez-Giménez, L., Ramírez, B., Sáinz, N., Catalán, V., Gómez-Ambrosi, J., Frühbeck, G., Leptin administration activates irisin-induced myogenesis via nitric oxide-dependent mechanisms: but reduces its effect on subcutaneous fat browning in mice. Int. J. Obes. (Lond.) 39:3 (2015), 397–407.
110. [110] Gutierrez-Repiso, C., Garcia-Serrano, S., Rodriguez-Pacheco, F., Garcia-Escobar, E., Haro-Mora, J.J., Garcia-Arnes, J., Valdes, S., Gonzalo, M., Soriguer, F., Moreno-Ruiz, F.J., Rodriguez-Cañete, A., Martinez-Ferriz, A., Santoyo, J.S., Perez-Valero, V., Garcia-Fuentes, E., FNDC5 could be regulated by leptin in adipose tissue. Eur. J. Clin. Invest. 44:10 (2014), 918–925.
111. [111] Suzuki, S.T., Zhao, B., Yang, J., Enhanced muscle by myostatin propeptide increases adipose tissue adiponectin: PPAR-alpha, and PPAR-gamma expressions. Biochem. Biophys. Res. Commun. 369:2 (2008), 767–773.
112. [112] Henningsen, J., Rigbolt, K.T., Blagoev, B., Pedersen, B.K., Kratchmarova, I., Dynamics of the skeletal muscle secretome during myoblast differentiation. Mol. Cell Proteomics 9 (2010), 2482–2496.
113. [113] Norheim, F., Raastad, T., Thiede, B., Rustan, A.C., Drevon, C.A., Haugen, F., Proteomic identification of secreted proteins from human skeletal muscle cells and expression in response to strength training. Am. J. Physiol. Endocrinol. Metab. 301 (2011), E1013–21.
114. [114] Alvarez-Llamas, G., Szalowska, E., de Vries, M.P., Weening, D., Landman, K., Hoek, A., Wolffenbuttel, B.H., Roelofsen, H., Vonk, R.J., Characterization of the human visceral adipose tissue secretome. Mol. Cell Proteomics 6:4 (2007), 589–600.
115. [115] Roca-Rivada, A., Alonso, J., Al-Massadi, O., Castelao, C., Peinado, J.R., Seoane, L.M., Casanueva, F.F., Pardo, M., Secretome analysis of rat adipose tissues shows location-specific roles for each depot type. J. Proteomics 74:7 (2011), 1068–1079.
116. [116] Yoon, J.H., Song, P., Jang, J.H., Kim, D.K., Choi, S., Kim, J., Ghim, J., Kim, D., Park, S., Lee, H., Kwak, D., Yea, K., Hwang, D., Suh, P.G., Ryu, S.H., Proteomic analysis of tumor necrosis factor-alpha (TNF-(α)-induced L6 myotube secretome reveals novel TNF-α-dependent myokines in diabetic skeletal muscle. J. Proteome Res. 10:12 (2011), 5315–5325.